Control and type 2 diabetes mice were treated with the NLRP3 selective inhibitor MCC950 (10 23 mg/kg/ day, intraperitoneal injections) or respective vehicle for 2 weeks and at the end of the 24 treatment, the animals were fasted for 8 h and fasting glycaemia was determined, characterizing 25 the time 0. After fasting glucose determination, a glucose overload at the dose of 2 g/kg was 26 administered, per gavage, to the animals. New blood samples were taken to determine the blood 27 glucose at 15, 30, 60, 90 and 120 minutes (min) after glucose administration. Blood was 28 collected after cutting at the tip of the tail and placed in individual tapes and the reading was 29 performed on a glucometer Accu-Chek Active® (Roche Diagnostics, Mannheim, Germany). 30 31 SUPPLEMENTARY FIGURE 1. Flow cytometry gating strategy for caspase-1 activity 32
in macrophages of the peritoneal lavage. Activity of caspase-1 in macrophages was 33 determined by flow cytometry in the peritoneal lavage of control and db/db mice treated with 34 vehicle or spironolactone for 6 weeks as indicated in the text. Total cells were stained with 35 allophycocyanin (APC) and FAM-FLICA® Caspase-1 (FAM-YVAD-FMK). Fluorophores 36
were respectively excited and analyzed with the appropriate laser and band pass filter (BP): 37
(FITC 492 nm with 520 nm and APC 633-647 nm with 660 nm 
